Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
Maurin
N
N
Medical Clinic II, University Hospital, Aachen, FRG.
D002482:Cellulose / Q000031:analogs & derivatives; D011464:Epoprostenol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007970:Leukopenia / Q000209:etiology; D008567:Membranes, Artificial; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D008567:Membranes, Artificial; D010975:Platelet Aggregation Inhibitors; C039188:taprostene; D002482:Cellulose; D006493:Heparin; C009865:cuprammonium cellulose; D011464:Epoprostenol